Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation

Obesity

Volumn 15, Issue 3, 2007, Pages 646-652

  Saleh, Jumana ^a   Cianflone, Katherine ^b   Chaudhary, Taqdees ^a   Al Riyami, Homed ^a   Al Abri, Abdul Raheem ^a   Bayoumi, Riad ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Acylation stimulating protein; Hyperlipidemia; Late gestation; Pregnancy; Very low density lipoproteins

Indexed keywords

COMPLEMENT COMPONENT C3; TRIACYLGLYCEROL;

ARTICLE; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; PREGNANCY; PREGNANCY COMPLICATION; STATISTICAL MODEL; THIRD TRIMESTER PREGNANCY;

COMPLEMENT C3; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; LINEAR MODELS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; TRIGLYCERIDES;

EID: 34247372682     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.575     Document Type: Article

References (41)

1. Boyd EM. The lipemia of pregnancy. J Clin Invest. 1934; 13: 347-63.
2. Montes A, Walden CE, Knopp RH, Cheung M, Chapman MB, Albers JJ. Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum. Arteriosclerosis. 1984;4:407-17.
3. Norton M, Buchanan TA, Kitzmiller J. Endocrine pancreas and maternal metabolism. In: Tulchinsky D, Brian Little A, eds. Maternal-Fetal Endocrinology. 2nd ed. Philadelphia, PA: WB Saunders Company; 1994, pp. 48-77.
4. O'SulIivan A, Martin A, Brown MA. Efficient fat storage in premenopausal women and in early pregnancy: a role for estrogen. J Clin Endocrinol Metab. 2001;86:4951-6.
5. Blackburn ST, Loper DL. Carbohydrate, fat, and protein metabolism. In: Eoyang T, ed. Maternal, Fetal and Neonatal Physiology, A Clinical Perspective. Philadelphia, PA: WB Saunders Company; 1992, pp. 583-613.
6. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(Suppl 5):1256-61S.
7. Ramos MP, Crespo-Solans MD, del Campo S, Cacho J, Herrera E. Fat accumulation in the rat during early pregnancy is modulated by enhanced insulin responsiveness. Am J Physiol Endocrinol Metab. 2003;285:E318-28.
8. Boden G. Fuel metabolism in pregnancy and gestational diabetes mellitus. Obstet Gynecol Clin North Am. 1996;23:1-10.
9. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002;13:51-9.
10. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD. The adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry. 1994;33:9489-95.
11. Cianflone K, Maslowska M. Differentiation induced production of ASP in human adipocytes. Eur J Clin Invest. 1995;25:817-25.
12. Sniderman AD, Maslowska M, Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol. 2000;11:291-6.
13. Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res. 1998;39:884-91.
14. Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman A. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res. 2004;45:124-31.
15. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology. 2000;141:1041-9.
16. Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest. 1999;29:679-86.
17. Koistinen HA, Vidai H, Karonen SL, Dusserre E, Valuer P, Koivisto VA. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol. 2001;21:1034-9.
18. Cianflone K, Zhang XJ, Genest Jr J, Sniderman AD. Plasma acylation stimulating protein in coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17:1239-44.
19. Cianflone KM, Maslowska MH, Sniderman AD. Impaired response of fibroblasts from patients with hyperapobetali-poproteinemia to acylation-stimulating protein. J Clin Invest. 1990;85:722-30.
20. Kwiterovich PO, Motevalli M Jr, Miller M. The effect of three serum basic proteins on the mass of lipids in normal and hyperapoB fibroblasts. Arterioscler Thromb. 1994;14:1-7.
21. Ozata M, Oktenli C, Gulec M, et al. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome. J Clin Endocrinol Metab. 2002;87:853-8.
22. Cianflone K, Sniderman AD, Kalant D, Marliss EB, Gougeon R. Response of plasma ASP to a prolonged fast. Int J Obes. 1995;19:604-9.
23. Sniderman AD, Cianflone K, Eckel RH. Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obes. 1991;15:333-6.
24. Murray IA, Sniderman AD, Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein (ASP) in C57B1/6 mice. Am J Physiol Endocrinol Metab. 1999;277:E474-80.
25. Saleh J, Blevins JE, Havel PJ, Barrett JA, Gietzen DW, Cianflone K. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord. 2001;25:705-13.
26. Murray I, Sniderman AD, Havel PJ, Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem. 1999;274:36219-25.
27. Xia Z, Sniderman AD, Cianflone K. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem. 2002;277:45874-79.
28. Ahrén B, Havel PJ, Pacini G, Cianflone K. Acylation stimulating protein stimulates insulin secretion, bit J Obes Relat Metab Disord. 2003;27:1037-43.
29. Saleh J, Christou N, Cianflone K. Regional specificity of ASP binding in human adipose tissue. Am J Physiol. 1999;276:E815-21.
30. Contois J, Lammi-Keefe C, Vogel S, et al. Plasma lipoprotein (a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay. Clin Chim Acta. 1996;253:21-35.
31. Painter P, Cope J, Smith J. Reference information for the clinical laboratory. In: Burtis C, Ashwood E, eds. Tietz Text Book of Clinical Chemistry. 3rd ed. Philadelphia, PA: W.B. Saunders; 1999, p. 1799.
32. Winkler K, Wetzka B, Hoffmann MM, et al. Low density lipoprotein (LDL) subfractions during pregnancy: accumulation of buoyant LDL with advancing gestation. J Clin Endocrinol Metab. 2000;85:4543-50.
33. Ryan AE. Hormones and insulin resistance during pregnancy. Lancet. 2003;362:1777-8.
34. Kildsgaard J, Zsigmond E, Chan L, Wetsel RA. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia. Mol Immunol. 1999;36:869-76.
35. Kalant D, Maclaren R, Cui W, et al. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem. 2005;280:23936-44.
36. Marcil M, Vu H, Cui W, et al. Identification of a novel C5L2 variant (S3231) in a French Canadian family with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2006;7:1619-25.
37. Batista MR, Smith MS, Snead WL, Connolly CC, Lacy DB, Moore MC. Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1064-73.
38. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005;280:35983-91.
39. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci U S A. 2000;97:12729-34.
40. Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol. 1982;142:735-8.
41. Li SH, Huang HL, Chen YH. Ovarian steroid-regulated synthesis and secretion of complement C3 and factor B in mouse endometrium during the natural estrous cycle and pregnancy period. Biol Reprod. 2002;66:322-32.